These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 1457207)

  • 1. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function.
    Chiou SH; Freed EO; Panganiban AT; Kenealy WR
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1611-8. PubMed ID: 1457207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.
    Freed EO; Myers DJ; Risser R
    J Virol; 1991 Jan; 65(1):190-4. PubMed ID: 1985197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.
    Lederman S; Bergmann JE; Cleary AM; Yellin MJ; Fusco PJ; Chess L
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1599-610. PubMed ID: 1457206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
    Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    Page KA; Stearns SM; Littman DR
    J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
    Clements GJ; Price-Jones MJ; Stephens PE; Sutton C; Schulz TF; Clapham PR; McKeating JA; McClure MO; Thomson S; Marsh M
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):3-16. PubMed ID: 2015114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release.
    Berger EA; Sisler JR; Earl PL
    J Virol; 1992 Oct; 66(10):6208-12. PubMed ID: 1527858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.
    Ivanoff LA; Dubay JW; Morris JF; Roberts SJ; Gutshall L; Sternberg EJ; Hunter E; Matthews TJ; Petteway SR
    Virology; 1992 Apr; 187(2):423-32. PubMed ID: 1546447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells.
    Travis BM; Dykers TI; Hewgill D; Ledbetter J; Tsu TT; Hu SL; Lewis JB
    Virology; 1992 Jan; 186(1):313-7. PubMed ID: 1727607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H; Usami O; Xiao P; Gu HX; Hattori T
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):213-8. PubMed ID: 15018709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages.
    Rabehi L; Seddiki N; Benjouad A; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1605-15. PubMed ID: 9870313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion.
    Freed EO; Risser R
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):807-11. PubMed ID: 1720627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.